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Abstract   
 
Background: Some studies have suggested that overweight is associated with lower mortality, 
but these results may be affected by reverse causality. We analyzed how body mass index 
(BMI) in young adulthood is associated with mortality in the general population and after the 
diagnoses of coronary heart disease (CHD), stroke, and cancer.  
 
Methods: BMI was measured at an average age of 18 years in 734,438 Swedish men born in 
1950-65. Diagnoses of CHD, stroke, and cancer as well as all-cause mortality were derived 
from registers covering the whole population until December 31st, 2010. The follow-up of 
24.56 million person-years included 33,067 cases of mortality and 19,843 CHD, 13,578 
stroke, and 27,365 cancer diagnoses. Hazard ratios (HR) with 95% confidence intervals were 
estimated by the Cox proportional hazards model.  
 
Results: Higher mortality in the whole cohort (HR=1.26, 1.21-1.32) as well as after the 
diagnosis of CHD (HR=1.33, 1.09-1.63) or cancer (HR=1.13, 1.01-1.25) was found in 
moderately overweight men (BMI 25.0-27.4 kg/m2) as compared to normal weight men (BMI 
20.1-22.4 kg/m2); for stroke patients the result for the same BMI categories was not 
statistically significant (HR=1.17, 0.94-1.45). Mortality increased with increasing weight 
status and was highest in obese men (BMI>30 kg/m2): HR=2.17 (2.02-2.34) for the whole 
cohort, 2.35 (1.81-3.05) after the diagnosis of CHD, 2.08 (1.56-2.77) after stroke, and 1.68 
(1.40-2.01) after cancer.  
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Conclusions: Even moderate overweight in young adulthood increases all-cause mortality and 
mortality after the diagnosis of CHD, stroke and cancer in men. Preventing overweight in 
young adulthood remains as an important public health issue.  
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The prevalence of obesity has strongly increased worldwide over the last decades. In 2008, 
10% of the world population was estimated to be obese, meaning that this prevalence has 
increased two-fold since 1980.1 Obesity is an important risk factor of atherosclerotic coronary 
artery disease2 and also increases the risk of stroke3 and several cancers.4 Even though these 
disease groups represent the most important causes of death in industrialized countries,5 the 
association between body mass index (BMI) and all-cause mortality is still under debate. A 
recent meta-analyses based on 141 studies found that even though obesity (BMI≥30 kg/m2) 
was associated with increased mortality, overweight (BMI 25.0-29.9 kg/m2) was associated 
with lower mortality, as compared to the normal weight category (BMI 18.5-24.9 kg/m2).6 A 
previous study also found that intentional weight loss was associated with higher mortality, 
further questioning whether high BMI is always a risk factor for mortality.7 However, other 
large studies have reported higher mortality related to overweight.8,9 Further, studies based on 
BMI in childhood or young adulthood have reported largely linear associations between BMI 
and later mortality with only weak evidence of higher all-cause mortality as well as CVD and 
cancer mortality in the lowest BMI categories.10-13 Thus, this question is still open.  
 
The possible beneficial effects of overweight on total mortality, at least in the presence of 
certain clinical conditions, have attracted substantial attention in previous scientific literature. 
Lower mortality in overweight patients as compared to normal weight patients has been 
found in diabetes,14 coronary artery disease,15 and chronic heart failure.16,17 These results 
seem to provide some evidence that the beneficial effects of overweight on all-cause 
mortality may be due to better opportunities to survive severe medical conditions. Studies 
from the US and the Netherlands also found that the medical treatment of patients with CVD 
was better in the overweight than in the normal weight group, which may contribute to the 
lower mortality of the overweight patients.18,19 These results have given rise to the so-called 
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“Obesity Paradox” suggesting that moderate overweight may increase chances of survival 
even when the well-known health risks related to obesity are taken into account.20 Since high 
BMI is a risk factor for cardiovascular diseases, the nature or severity of this category of 
diseases may also be different in lean and obese patients.   
 
However, from the public health point of view, the key issue is whether overweight really 
offers health benefits or if it is rather a proxy indicator of a lack of underlying diseases with a 
negative effect on survival per se. Both the severity of the main diagnosed disease and other 
underlying diseases also affecting survival can lead to weight loss and thus a spurious 
association between overweight and lower mortality. Thus, taking this reverse causality into 
account is difficult. In this study we aim to avoid the possibility of reverse causality by using 
a very large population-based cohort of Swedish men whose BMI was measured in early 
adulthood, minimizing the potential effects of underlying diseases on BMI. As compared to 
previous studies using BMI in young adulthood, the strength of our data is not only the large 
size but also the possibility to identify major disease diagnoses. Thus, we can analyze not 
only total mortality but also survival after major disease diagnoses.  
 
Data and methods 
 
The baseline measures were taken during the conscription examination in Sweden. In our 
study cohort born in 1950-1965, the conscription examination predated active military service 
and was mandatory by law for all male Swedish citizens. However, those with a severe 
handicap or a chronic disease were exempted from the examination based on a certificate 
issued by a physician. Age at the time of the conscription examination varied from 16 to 25 
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years, but only 1.4% of the conscripts were younger than 17 or older than 20 years. Thus our 
study cohort is likely to be mainly free from diseases affecting BMI.  
 
BMI was computed from height and weight measured in underwear dividing weight (kg) by 
squared height (m2). The WHO classification was used as the basis of our BMI classification 
because it has been used in most previous studies. 21 However, since our dataset is large and 
permits a more detailed BMI classification, we split both normal and overweight categories. 
Thus, we used seven BMI categories: less than 18.5 kg/m2 (underweight), 18.5-20.0 kg/m2 
(lower normal weight), 20.1-22.4 kg/m2 (normal weight), 22.5-24.9 kg/m2 (upper normal 
weight), 25.0-27.4 kg/m2 (lower overweight), 27.5-29.9 kg/m2 (upper overweight), and 30 
kg/m2 or more (obese). In total we had 746,752 participants at baseline and for 734,438 
participants we also had measures of systolic blood pressure (SBP), diastolic blood pressure 
(DBP), and muscle strength. Occupational socio-economic position was derived from 
censuses in 1980, 1985 and 1990 and classified into seven categories (higher-level non-
manuals, middle-level non-manuals, lower-level non-manuals, farmers, skilled workers, 
unskilled workers, no previous occupation). Education was based on entries in the Swedish 
Register of Education for the period of 1990-2010 and classified into five categories (higher 
education, secondary education, basic education, less than basic education and missing). 
More detailed information on the measurements has been reported previously in this 
journal.22   
 
We then identified diagnoses of coronary heart disease (CHD) and stroke from the Swedish 
Hospital Discharge Register using the first hospitalization for each and the first registered 
cancer diagnosis from the Cancer Register and linked them to the baseline data available 
from the Swedish Military Service Conscription Register. During the follow-up until 
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December 31st, 2010, the Eighth, Ninth, and Tenth Revisions of the International 
Classification of Diseases (ICD) were used for CHD (410-414 for ICD8 and ICD9 and I20-
I25 for ICD10) and stroke diagnoses (430-438, 344 for ICD8, 430-438, 342, 344 for ICD9 
and I60-I66, G45 for ICD10). For cancer diagnoses, ICD9 was used during the whole follow-
up period (140-209). We then followed up the mortality of all participants based on linkage 
with the Swedish Cause of Death Register. Hospital discharge, cancer, and cause of death 
registers cover the entire Swedish population. The register linkages were done using the 
unique personal identity numbers assigned to all Swedish citizens a few days after birth. 
Thus, we repeated all mortality analyses in four cohorts: one including all participants with 
follow-up starting from the conscription examination and three sub-cohorts for those having 
diagnoses of CHD, stroke, and cancer with follow-up starting from the date of diagnosis. In 
total we had 33,067 cases of mortality and 19,843 diagnoses of CHD, 13,578 diagnoses of 
stroke, and 27,365 diagnoses of cancer during the 24.56 million person-years of follow-up. 
The participants were 45 to 60 years of age at the end of follow-up on 31st December 2010. 
The median age was 43 years at mortality, 49 years at CHD diagnosis, 48 years at stroke 
diagnoses and 47 years at cancer diagnoses.  
 
The data were analyzed using the Cox proportional hazards model. We estimated hazard 
ratios (HR) with 95% confidence intervals (CI) for total mortality first after the conscription 
examination and then after the diagnoses of CHD, stroke, and cancer. Emigrants were 
identified from the Swedish population register and censored on the date of emigration. All-
cause mortality was used instead of cause-specific mortality, which is also available in the 
Swedish Cause of Death Register, because we wanted to analyze the association between 
BMI and total survival after diagnosis. Age at the conscription examination was adjusted for 
when analyzing mortality in the whole cohort and age at the time of diagnosis was adjusted 
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for when analyzing survival after diagnosis. Further, all models were adjusted for the 
conscription office. Swedish conscripts are required to enlist at the conscription office closest 
to their residence, and thus adjusting the results for the conscription office takes possible 
geographic variation in Sweden into account. We further stratified age at conscription (or 
CHD, stroke and cancer diagnoses) into five-year categories, thus allowing different baseline 
hazards rates in each five-year category. The basic model (Model 1) was thus adjusted for age 
at baseline (age at conscription for total mortality and age at diagnosis for mortality after 
CHD, stroke, and cancer diagnoses), conscription office, and birth cohort. To test the shape 
of the association, we also calculated the basic model by using restricted cubic splines with 
four knots placed at the fifth, 35th, 65th, and 95th percentiles and present these results as a 
graph. We then adjusted the results for the three muscle strength measures used as proxy 
indicators of body composition in early adulthood (Model 2), then additionally for DBP and 
SBP (Model 3), and finally also for education and socio-economic position (Model 4). 
Proportional hazards assumptions were tested for BMI both by testing the correlation of 
Schoenfeld residuals with follow-up time and comparing Kaplan-Meier curves. We did not 
find any evidence of violations for mortality after the diagnosis of CHD (p=0.44), stroke 
(p=0.66), or cancer (p=0.39), and the Kaplan-Meier curves were parallel. For total mortality 
(regardless of a prior diagnosis of CHD, stroke, or cancer) the testing of Schoenfeld residuals 
indicated a violation of the proportional hazards assumption (p<0.0001). However, the 
Kaplan-Meier curves appeared parallel, and this statistically significant result is likely to be 
due to the high statistical power in these analyses (the Kaplan-Meier curves are not shown 
but are available from the corresponding author). All analyses were done with Stata statistical 
software, version 11.0 for Windows. 
 
Results 
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Table 1 presents the baseline characteristics of the participants and mortality as well as the 
incidence rates during the follow-up by BMI categories. Mean BMI was low in this young 
cohort (21.4 kg/m2 SD=2.72), and 42% of the participants were in the normal weight 
category. SBP and DBP increased monotonically from the underweight to the obese category. 
As expected, a monotonic increase with BMI was also found in all strength measures. The 
proportion of overweight and obesity was lowest in men with higher education (6%) and 
higher-level non-manuals (5.1%) and highest in men with less than basic education (11.5%) 
and unskilled workers (11.6%). Mortality was lowest in the normal weight category and then 
increased up to the obese category. There was also a monotonic increase in mortality with 
decreasing BMI between the normal and underweight categories, with mortality in the 
underweight category being intermediate between that in the upper and the lower overweight 
categories. The same pattern was also found for stroke hospitalization incidence. However for 
CHD hospitalization, the incidence increased from the lower normal weight category to the 
obese category. For cancer, a somewhat higher incidence was found in the overweight and 
obese categories as compared to the normal and underweight categories, but the differences 
were smaller than for CHD and stroke.   
 
Table 2 presents HRs by BMI categories for mortality after conscription and after diagnoses 
of CHD, stroke, and cancer. In Model 1 adjusted only for age at the time of conscription or 
diagnoses and conscription office, total mortality and mortality after diagnoses of CHD and 
cancer increased monotonically up to the obese category when compared to the normal 
weight category. For mortality after stroke, the increase occurred after the upper normal 
weight category. HRs in the overweight categories were substantially higher as compared to 
the normal weight categories and they were highest in the obese category. In the underweight 
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category, the mortality was higher than in the normal weight category for all mortality 
outcomes, but the HR was statistically significant only for total mortality, and the HR for 
mortality was at approximately at the same level as seen in the upper normal weight category. 
The same J-shaped association was confirmed when we estimated the shape of these 
association using splines (Figure 1). 
 
We then adjusted the model for possible confounding factors (Table 2). Adjusting the results 
for muscle strength (Model 2) with further adjustment for DBP and SBP (Model 3) had only 
little effect on the associations between the BMI categories and mortality. Further adjustment 
of education and social position somewhat decreased the differences in mortality between 
BMI categories. However, the monotonically increasing pattern of mortality was still found 
after the normal weight (total mortality and mortality after the diagnosis of CHD or cancer) 
or upper normal weight category (mortality after the diagnosis of stroke), and most of the HR 
differences remained statistically significant.   
 
Discussion 
 
Based on our results, not only obesity but also overweight in early adulthood increases 
mortality after the diagnoses of CHD, stroke, and cancer. Muscle strength used as a proxy 
indicator of body composition, SBP, and DBP had only little effect on these associations in 
our cohort. Socio-economic factors somewhat explained the differences in mortality between 
the BMI categories, but overweight and obesity were still found to be associated with higher 
mortality even after an adjustment for education and social position. These results are 
different from, but not necessarily in contrast to, the previous findings showing lower 
survival among overweight patients with cardiovascular diseases as compared to normal 
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weight patients.14-17 In these previous studies, BMI was measured at the time of the 
cardiovascular diagnoses, whereas in our data it was measured decades before the diagnoses 
in a population mainly free from all diseases potentially affecting BMI. Thus, a likely reason 
for these inconsistent results is that high BMI is a risk factor for survival by itself, but reverse 
causality due to disease-related weight loss may reverse this association when BMI is 
measured close to the time of the cardiovascular event.  
 
In addition to CHD and stroke diagnoses, we found an association between increased 
mortality and overweight or obesity after a cancer diagnosis. The results on cancer are 
consistent with a previous study which showed that obese patients had an increased risk of 
mortality after a diagnosis of colorectal cancer as compared to normal weight patients when 
using BMI measured seven years before the diagnosis.23 In our cohort overweight and obesity 
were associated with an increased risk of cancer, but these associations were weaker than the 
risk of CHD, and the overweight participants had only a slightly higher incidence of cancer 
than the normal weight participants.  
 
We also found that not only mortality after diagnoses but also mortality in the whole cohort 
was lowest in the normal weight category. Our results on total mortality are broadly 
consistent with the results of two large meta-analyses based on pooled individual-based data 
which showed that the nadir of mortality was within the BMI category of 20.0-25.0 kg/m2 and 
increased linearly at higher BMI levels.8,9 These results, on the other hand, contrast with the 
meta-analysis based on estimates extracted from published papers which showed that the 
lowest mortality was seen in the overweight category (BMI 25.0-29.9 kg/m2).6 In addition to 
underlying diseases resulting in weight loss, another possible explanation is the effect of 
smoking. Even though the increased risk of mortality in the overweight category as compared 
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to the normal weight category was found in all participants in the two individual-based meta-
analyses, the difference was stronger in non-smokers.8,9 We had access to information on 
smoking for a large sub-cohort of men. In our previous study using this sub-cohort, we did 
not find any interaction effect between smoking and BMI when predicting all-cause 
mortality.24 This result was expected because the cohort was young at baseline, and thus the 
participants who were smokers had not been smoking for a very long time before the 
measurement of BMI. Therefore the role of smoking is very different in comparison with 
middle-age cohorts where long-time smoking may have decreased BMI or BMI may have 
increased after the quitting of smoking, thus affecting the association between BMI and 
mortality. 
 
The mean BMI in our cohort was low, reflecting the young age of the participants at baseline. 
BMI has been found to increase in a monotonically fashion from young adulthood to middle 
age.25 A large part of this weight gain is due to the accumulation of fat mass, which is stored 
in men particularly in the abdominal cavity.26 Thus, our study participants are likely to have 
been heavier at the time of disease onset but may have subsequently lost weight because of 
the effect of illness. These results indicate that even relatively minor overweight in young 
adulthood is a risk factor for further mortality, probably because many of these men are likely 
to become obese in middle age.     
 
In addition to the early age at baseline, our study differed from previous research because the 
participants were relatively young at the end of follow-up in spite of the long follow-up time.  
Therefore, we cannot rule out the possibility that many of the men who were in the normal 
BMI range in young adulthood might have become moderately obese in mid-life and 
experienced increased mortality in that part of life. By contrast, previous research suggests 
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that high BMI in old age is associated with better health outcomes, due to higher muscle mass 
rather than fat mass.27 Thus more detailed anthropometrical measures enabling fat mass to be 
differentiated from muscle mass, in addition to a longer follow-up time, would be needed to 
analyze this issue correctly. 
 
Our data have strengths, but also limitations. Our main strength is that we have BMI 
measured in early adulthood and thus minimally affected by underlying diseases which may 
cause reverse causality. Since the conscription examination was mandatory under Swedish 
law in our study cohorts, our baseline data are not prone to self-selection, and because of the 
universal health care system in Sweden, our follow-up data on hospitalization, cancer 
diagnoses, and mortality also cover the whole Swedish population. Further, we have 
measures of muscle strength and blood pressure at baseline and also register-based 
information on education and occupational socio-economic position used as covariates in this 
study. A limitation of our data is that the study participants were relatively young at the end 
of the follow-up; therefore, our results cannot be generalized to old age. Moreover, we do not 
have repeated measures of BMI after young adulthood and thus cannot study how different 
trajectories of weight change are associated with survival. Most men increase in weight 
during aging, but those with diseases may lose weight. Further, our data include only men, 
and thus further studies are needed to analyze whether similar results can be obtained for 
women.  
 
In conclusion, our results show that overweight and obesity in early adulthood are risk factors 
for all-cause mortality and decrease the chances of survival after the diagnosis of CHD, 
stroke, and cancer in later life. Overweight in young adulthood thus remains an important 
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public health problem in terms of all-cause mortality in the general population as well as 
survival after CHD, stroke and cancer.  
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Table 1. Baseline characteristics (mean and SD or proportion), mortality and coronary heart disease, stroke, and cancer hospitalizations 
(incidence rates and number of cases) according to baseline BMI. 
 
 Baseline BMI (kg/m2)  
  
 Underweight Lower normal  Normal weight Upper normal Lower   Upper  Obese 
   weight    weight  overweight overweight 
 <18.5  18.5-20.0 20.1-22.4 22.5-24.9 25.0-27.4 27.5-29.9 ≥30  
 
Baseline anthropometric characteristics: means (SD)  
BMI (kg/m2) 17.7   (0.69)  19.3  (0.42)  21.2   (0.71)  23.5   (0.69)  26.0  (0.73)  28.6  (0.67)  32.6   (2.66) 
DBP (mm Hg) 68  (9.3)  68.4  (9.4)  69  (9.6)  69  (9.8)  71  (10.1)  72  (10.4)  74  (10.8) 
SBP (mm Hg) 125  (10.8)  127  (10.8)  128  (10.9)  130  (10.9)  132  (10.9) 134  (11.4)  137  (11.3)  
Elbow flexion strength (N) 308  (59)  346  (65)  383  (74)  418  (83)  436  (90)  447  (94)  457  (99) 
Hand grip strength (N) 551  (86)  590  (88)  623  (93)  650  (100)  656   (105)  657  (110)  660  (112) 
Knee extension strength (N) 455  (87)  505 (92)  552  (102)  595  (113)  613  (120)  627  (127)  641  (134) 
 
Socio-economic variables, % 
Education  
Higher education  9.4    21.3    44.7    18.6  4.3    1.1    0.6 
Secondary education  10.1  20.6  40.6  19.1  6.2  2.0  1.4  
Basic education  10.8  20.8  38.5  18.7  7.0  2.4  1.8 
Less than basic education  11.1  20.3  38.4  18.7  7.2  2.5  1.8  
Missing 9.2  20.7  41.9  18.7  6.0  2.0  1.5 
 
Social position, % 
Higher-level non-manuals 10.4  22.5  44.8  17.2  3.7  0.9  0.5  
Middle-level non-manuals 9.8  21.2  43.3  18.9  4.8  1.3  0.7 
Lower-level non-manuals 10.5  21.1  41.7  18.6  5.4  1.6  1.1  
Farmers 8.8  19.9  41.5  19.9  6.5  2.1  1.3  
Skilled workers 9.5  20.0  40.5  19.7  6.6  2.2  1.5 
Unskilled workers 10.3  20.4  38.7  18.8  7.1  2.5  2.0 
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No previous occupation 10.6  21.2  41.8  18.2  5.0  1.8  1.4 
 
Incidence rates per 10 000 person years (number of cases) 
Mortality 14.71  (3691)  13.16  (6810)  12.6  (12,789)  13.2  (6031)  15.3  (2120)  20.0  (873)  25.5  (753) 
CHD 7.05  (1760)  7.01  (3613)  7.30  (7402)  9.08  (4123)  12.23  (1683)  16.38  (708)  18.99  (554) 
Stroke 5.72  (1430)  5.34  (2753)  5.18  (5255)  5.48  (2494)  7.03  (970)  8.08  (351)  11.08  (325) 
Cancer 11.19   (2784)  11.12  (5707)  11.12  (11,236)  11.22  (5078)  11.98  (1647)  12.87  (557)  12.16  (356) 
Mean age at baseline (year) 18.4  18.4  18.4  18.5  18.5  18.5  18.5 
Median follow-up time (year) 35.2   34.8   34.1   33.6   33.2   33.0   31.9 
Million person years 2.51   5.17   10.18   4.57   1.39   0.44   0.30 
Number of participants 73,325  15,2954 30,4873 138,382 42,313  13,404  9187  
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Table 2. Hazard ratios (HR) with 95% confidence intervals (CI) of total mortality and mortality after diagnosis of coronary heart disease, stroke 
and cancer. 
 
 Model 1 Model 2 Model 3 Model 4 
 HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
 
Total mortality 
Underweight (<18.5) 1.11  1.07-1.15  1.05  1.01-1.09  1.05  1.01-1.09  1.03  0.99-1.08 
Lower normal weight (18.5-20.0) 1.02 0.99-1.05  1.00  0.97-1.03  1.00  0.97-1.03  0.97  0.94-1.00 
Normal weight (20.1-22.4) 1.00  1.00  1.00  1.00 
Upper normal weight (22.5-24.9) 1.08  1.05-1.12  1.10  1.07-1.14  1.10  1.06-1.13  1.09  1.05-1.12 
Lower overweight (25.0-27.4) 1.26  1.21-1.32  1.29  1.23-1.35  1.27  1.21-1.33  1.19  1.13-1.25 
Upper overweight (27.5-29.9)  1.66  1.55-1.78  1.70  1.58-1.82  1.66  1.54-1.78  1.51  1.40-1.62 
Obese (≥30) 2.17  2.02-2.34  2.22  2.06-2.40  2.14  1.98-2.30  1.91  1.77-2.07 
 
Mortality after coronary heart disease 
Underweight (<18.5) 1.19  0.97-1.47  1.13  0.91-1.41  1.14  0.92-1.42  1.12  0.90-1.39 
Lower normal weight (18.5-20.0) 0.99  0.83-1.18  0.96  0.81-1.15  0.97  0.82-1.16  0.98  0.82-1.17 
Normal weight (20.1-22.4) 1.00  1.00  1.00  1.00 
Upper normal weight (22.5-24.9) 1.12  0.95-1.31  1.14  0.97-1.34  1.14  0.97-1.34  1.12  0.95-1.31 
Lower overweight (25.0-27.4) 1.33  1.09-1.63  1.37  1.11-1.68  1.34  1.09-1.65  1.27  1.04-1.57 
Upper overweight (27.5-29.9) 1.96  1.53-2.51  2.02  1.57-2.60  1.97  1.52-2.54  1.85  1.43-2.38 
Obese (≥30) 2.35  1.81-3.05  2.43  1.86-3.18  2.29  1.74-3.01  2.08  1.58-2.74 
 
Mortality after stroke 
Underweight (<18.5) 1.12 0.93-1.35  1.08  0.89-1.31  1.08  0.89-1.31  1.01  0.83-1.23 
Lower normal weight (18.5-20.0) 1.15  1.00-1.34  1.13  0.98-1.32  1.14  0.98-1.32  1.12  0.96-1.31 
Normal weight (20.1-22.4) 1.00  1.00  1.00  1.00 
Upper normal weight (22.5-24.9) 0.98  0.83-1.15  0.99  0.84-1.17  0.99  0.84-1.16  0.97  0.82-1.14 
Lower overweight (25.0-27.4) 1.17  0.94-1.45   1.18  0.95-1.47   1.17  0.94-1.46   1.10  0.88-1.37 
Upper overweight (27.5-29.9) 1.67  1.23-2.25  1.71   1.27-2.32  1.68   1.24-2.29  1.61  1.18-2.19 
Obese (≥30) 2.08  1.56-2.77   2.14  1.59-2.87   2.07  1.53-2.79  1.83   1.35-2.47 
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Mortality after cancer 
Underweight (<18.5) 1.05  0.96-1.14   1.01  0.92-1.10   1.01  0.92-1.11   0.98 0.90-1.08 
Lower normal weight (18.5-20.0) 1.02  0.95-1.09   1.00  0.94-1.07  1.00  0.94-1.07  0.98  0.92-1.06  
Normal weight (20.1-22.4) 1.00  1.00  1.00  1.00 
Upper normal weight (22.5-24.9) 1.07  0.99-1.14  1.08  1.00-1.16   1.08  1.00-1.16   1.05  0.98-1.13 
Lower overweight (25.0-27.4) 1.13  1.01-1.25  1.14   1.03-1.27    1.15   1.03-1.28    1.09   0.98-1.22 
Upper overweight (27.5-29.9) 1.39  1.19-1.63    1.42   1.21-1.66    1.42   1.21-1.66   1.26    1.07-1.49 
Obese (≥30) 1.68  1.40-2.01   1.71  1.42-2.06   1.71   1.42-2.06   1.54  1.27-1.86 
 
Model 1 = age at baseline, conscription office, and birth cohort; Model 2 = Model 1+ elbow flexion, hand grip, and knee extension strength; 
Model 3 = Model 2 + systolic blood pressure and diastolic blood pressure; Model 4 = Model 3 + own education and occupation based socio-
economic position.  
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Figure 1. Association between BMI and mortality in the total cohort and after the diagnosis of 
coronary heart disease, stroke and cancer. 95% confidence intervals are shown with dotted 
lines. The results are adjusted for age at baseline, conscription office, and birth cohort.  
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